LATAYA DE JESUS: Open Payments
NPI 1154071264 · BEACHWOOD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$618 in 37 payments from 12 companies in 2025. Trend: 2023 $463 · 2024 $327 · 2025 $618
Food & beverage: $533Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $208 |
| Astellas Pharma US Inc | 3 | $116 |
| Novo Nordisk Inc | 4 | $64 |
| Lilly USA, LLC | 3 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
Products named: VRAYLAR, Ozempic, MOUNJARO, CAPLYTA, LINZESS, QULIPTA, CREON, Veozah.
Industry payments across OH — which companies pay providers there.
